DAKIMA BRIDGES: Open Payments
NPI 1659645125 · BRIDGEPORT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 13 payments from 9 companies in 2025. Trend: 2023 $152 · 2024 $139 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| PFIZER INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: The Cologuard Plus Collection Kit, FARXIGA, REXULTI, Auvelity, CAPLYTA, ELIQUIS, Wegovy, ZEPBOUND.
Industry payments across MI — which companies pay providers there.
